Intravenous tranexamic acid is associated with an increased risk of pulmonary embolism following sarcoma resection.
Devon FosterRonnie SebroHillary GarnerRupert StanboroughAaron C SpauldingKrista A GouldingMatthew T HoudekBenjamin K WilkePublished in: Journal of surgical oncology (2023)
Our results demonstrate a higher associated risk of PE following TXA use in sarcoma surgery and caution is warranted with TXA use in this patient population.